Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
Clinical trial NCT02305381 · COMPLETED
Trial details
- NCT number
- NCT02305381
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-11-21
- Enrollment
- 397
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.